advertisement
11.3.4 Betablocker (16)
Showing records 1 to 16
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker15671 Ocular blood flow: reproducibility of Heidelberg Retina Flowmeter data and no effect of metipranolol in healthy volunteers
Funk J; Müller-Velten R; Ness T
Klinische Monatsblätter für Augenheilkunde 2000; 217: 263-268
15672 Effect of topical timolol on optic nerve head circulation in the cynomolgus monkey
Ishii K; Araie M
Japanese Journal of Ophthalmology 2000; 44: 630-633
15675 A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms
Oruç S; Sener EC
International Ophthalmology 1999; 23: 69-73
15873 Contralateral effect of topical β-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study
Piltz J; Gross R; Shin DH; Beiser JA; Dorr DA; Kass MA; Gordon MO
American Journal of Ophthalmology 2000; 130: 441-453
15935 Efficacy of timolol hydrogel 0.1% in patients with primary open-angle glaucoma and ocular hypertension
Ardjomand N; Komericki P
Spektrum der Augenheilkunde 2000; 14: 203-208
15907 Comparative study of timolol gel versus timolol solution for patients with glaucoma
Chiou S-H; Hsu W-M; Liu J-H; Liu J-L; Chen M-R; Tsai D-C; Chou C-K
Zhonghua Yi Xue Za Zhi 2000; 63: 737-743
15666 A comparison of dorzolamide-timolol combination versus the concomitant drugs
Choudhri S; Wand M; Shields MB
American Journal of Ophthalmology 2000; 130: 832-833
15791 Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial
Heijl A; Bengtsson B
Graefe's Archive for Clinical and Experimental Ophthalmology 2000; 238: 877-883
15762 Stability indicating HPTLC determination of timolol maleate as bulk drug and in pharmaceutical preparations
Kulkarni SP; Amin PD
Journal of Pharmacological and Biomedical Analysis 2000; 23: 983-987
15763 Effect of carteolol hydrochloride on ocular blood flow dynamics in normal human eyes
Mizuki K; Yamazaki Y
Japanese Journal of Ophthalmology 2000; 44: 570
16002 A comparison between latanoprost and timolol in treatment of patients with primary open-angle glaucoma and ocular hypertension
Peng D; Li S; Li M
Chinese Journal of Ophthalmology 2000; 36: 285
15669 Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension: a three-month randomised study
Sanchez JG
European Journal of Ophthalmology 2000; 10: 198-204
15659 Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biological & Pharmaceutical Bulletin 2000; 23: 1352-1356
15767 A new long acting ophthalmic formulation of carteolol containing alginic acid
Sechoy O; Tissie G; Sebastian C; Maurin F; Driot J; Trinquand C
International Journal of Pharmaceutics 2000; 207: 109-116
15670 Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol versus 0. 12% unoprostone
Shimazaki J; Hanada K; Yagi Y; Yamagami J; Ishioka M; Shimmura S; Tsubota K
British Journal of Ophthalmology 2000; 84: 1250-1254
15876 Topical ophthalmic β blockers may cause release of histamine through cytotoxic effects on inflammatory cells
Van Beek LM; Mulder M; Van Haeringen J; Kijlstra A
British Journal of Ophthalmology 2000; 84: 1004-1007
